Главная
Рынки
Графики и идеи
Алготрейдинг
Новости
Store
Брокеры
Скачать
Экономический календарь
Торговые сигналы
Вебтерминал
Нажмите
/
для поиска: @user, $symbol, ...
Поиск
Вход
Создать аккаунт
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CLGN
#3898
CollPlant Biotechnologies Ltd Ordinary Shares
0.5
7
-1.72%
Сектор:
Базовая:
Валюта прибыли:
Дневной диапазон
Годовой диапазон
Дневное изменение
-1.72%
Месячное изменение
-70.62%
6-месячное изменение
-79.86%
Годовое изменение
-83.71%
Предыдущее закрытие
0.5
8
Open
0.5
7
Bid
Ask
Low
0.5
7
High
0.5
7
Объем
1
Рынки
Рынок акций США
Здравоохранение
CLGN
Open full chart
Financials
Overview
Отчетность
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
6.96 M
10.77 M
11.19 M
11.45 M
11.45 M
44.87 M
Valuation ratios
Enterprise value
—
163.33 M
109.87 M
42.61 M
29.33 M
345.14 M
Price to earnings ratio
—
818
-5.62
-9.76
-2.48
—
Price to sales ratio
—
12.52
317.35
6.29
80.07
—
Price to cash flow ratio
—
78.28
6.93
24.94
2.93
—
Price to book ratio
—
4.34
2.94
2.43
3.06
12.77
Enterprise value to EBITDA ratio
—
20.41
-19.03
11.33
-4.87
—
Profitability ratios
Return on assets %
0.53
0
0.45
0.21
0.89
—
Return on equity %
1.29
0.01
0.52
0.25
1.23
—
Return on invested capital %
13 K
1.94
419.83
-2 635.31
-1 658.9
—
Gross margin %
51.08
87.18
33.78
81.83
215.53
—
Operating margin %
91.23
0.42
5 718.06
68.55
3 349.71
—
EBITDA margin %
61.28
51.15
-1 931.44
34.33
-1 170.29
—
Net margin %
94.09
1.52
5 660.54
64.05
3 225.05
—
Liquidity ratios
Quick ratio
1.3
14.6
9.74
8.4
4.29
37.03
Current ratio
1.68
14.96
10.2
8.62
4.44
38.21
Inventory turnover
0.05
0.31
0.24
0.81
0.5
—
Asset turnover
0.57
0.5
0.01
0.3
0.02
—
Solvency ratios
Debt to assets ratio
—
0
1.15
—
—
—
Debt to equity ratio
—
0.01
1.34
—
—
—
Long term debt to total assets ratio
0.31
0
1.14
—
—
—
Long term debt to total equity ratio
0.75
0
1.33
—
—
—
Per share metrics
Operating cash flow per share
—
0.21
1.24
0.24
1.23
—
EBIT per share
—
0.6
-0.71
0.23
-0.62
—
EBITDA per share
—
0.67
-0.52
0.33
-0.53
—
Total debt per share
—
0.02
3.93
—
—
—
Cash per share
—
1.1
2.69
2.34
1.04
7.17
Net current asset value per share
—
3.77
2.87
2.46
1.15
10.25
Tangible book value per share
—
3.75
2.9
2.47
1.16
10.29
Working capital per share
—
3.52
2.59
2.17
0.89
9.17
Book value per share
—
3.77
2.93
2.49
1.18
10.36
Новости
CollPlant secures Korean patent for dermal filler technology
CollPlant推出用于3D生物打印的BioFlex生物墨水套装
CollPlant launches BioFlex bioink kit for 3D bioprinting
H.C. Wainwright重申Opko Health股票买入评级
D. Boral Capital将CollPlant评级从买入下调至持有
CollPlant stock rating downgraded to Hold from Buy by D. Boral Capital
CollPlant Biotechnologies定于12月31日召开年度和特别会议
CollPlant Biotechnologies schedules annual and extraordinary meeting for December 31
Collplant ADRQ3每股收益及营收逊于预期
Collplant ADR earnings missed by $0.41, revenue fell short of estimates
CollPlant股价小幅下跌,第三季度收入未达预期
CollPlant shares edge down as Q3 revenue falls short of estimates